INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY

Hafsah Nabi*, Merete Lund Hetland, Anne Gitte Loft, Oliver Hendricks, D Jensen, Jens Kristian Pedersen, Søren Just, Kamilla Danebod, Heidi Lausten Munk, S. Kristensen, N Manilo, Ada Colic, Asta Linauskas, Pia H Thygesen, L. B. Christensen, Maren Høgberget Kalisz, Niels Lomborg, Jolanta Grydehøj, Johnny Lillelund Raun, R AhmedFrank Mehnert, Niels Steen Krogh, Bente Glintborg

*Kontaktforfatter

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
TidsskriftAnnals of the Rheumatic Diseases
Vol/bind81
Udgave nummersuppl. 1
Sider (fra-til)45-46
ISSN0003-4967
DOI
StatusUdgivet - jun. 2022
BegivenhedEULAR 2022 -
Varighed: 1. jun. 20224. jun. 2022

Konference

KonferenceEULAR 2022
Periode01/06/202204/06/2022

Citationsformater